ANKRD23 Inhibitors
Chemical inhibitors of ANKRD23 target the protein through various direct and indirect mechanisms that hinge upon the specific cellular processes and biochemical pathways in which ANKRD23 is involved. Staurosporine, a broad-spectrum protein kinase inhibitor, can prevent the phosphorylation of ANKRD23. This inhibition could maintain ANKRD23 in an inactive state. Similarly, Ivermectin can alter the ionic balance, leading to the loss of ANKRD23 activity. Brefeldin A can disrupt the intracellular transport pathways; if ANKRD23 requires translocation to function effectively, this chemical would result in its functional inhibition due to mislocalization.
Furthermore, MG132 can lead to the accumulation of regulatory proteins that govern ANKRD23's activity by inhibiting the proteasome, which might otherwise degrade such regulators. This accumulation can inhibit ANKRD23. Cyclosporin A, through its inhibition of calcineurin, can keep ANKRD23 in a phosphorylated and potentially inactive state if dephosphorylation is necessary for its function. LY294002 and Rapamycin, inhibitors of the PI3K and mTOR pathways, respectively, can decrease ANKRD23 activity. U0126 and PD98059 focus on the MAPK/ERK pathway, its activity would be curtailed by these chemicals. WZB117, which inhibits glucose transport, can suppress ANKRD23 function by limiting the energy supply necessary for its activity. Thapsigargin, by disrupting calcium homeostasis, can inhibit ANKRD23. Lastly, KN-93 specifically inhibits CaMKII, this could result in functional inhibition of ANKRD23.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. If the activation of ANKRD23 is dependent on phosphorylation by a particular kinase, staurosporine can inhibit this kinase, thereby preventing the activation of ANKRD23. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Ivermectin is known to modulate ion channels. If ANKRD23 requires a specific ionic environment for its structure or activity, ivermectin can disrupt this environment, leading to functional inhibition of ANKRD23. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport by inhibiting the ADP-ribosylation factor. If ANKRD23 requires transport to a specific cellular location to function, Brefeldin A can inhibit this process, leading to functional inhibition of ANKRD23. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. By inhibiting the proteasome, MG132 can prevent the degradation of proteins that regulate or inhibit ANKRD23, thereby increasing their levels and inhibiting ANKRD23 function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin. If ANKRD23 activity is regulated by dephosphorylation via calcineurin, Cyclosporin A can maintain ANKRD23 in a phosphorylated and inactive state. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. If ANKRD23 activity is PI3K pathway-dependent, inhibition of PI3K by LY294002 can lead to a reduction in ANKRD23 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the PI3K/AKT/mTOR pathway. If ANKRD23 activity is mTOR pathway-dependent, Rapamycin can inhibit this pathway, leading to inhibition of ANKRD23. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
WZB117 inhibits GLUT1, a glucose transporter. If ANKRD23 requires energy from glucose metabolism, inhibition of GLUT1 by WZB117 can decrease the energy supply, thereby inhibiting ANKRD23 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is involved in the MAPK/ERK pathway. If ANKRD23 operates downstream of this pathway, PD98059 can inhibit MEK, leading to functional inhibition of ANKRD23. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, which leads to increased cytosolic calcium levels. If ANKRD23 function is disrupted by altered calcium levels, Thapsigargin can inhibit ANKRD23 by perturbing cellular calcium homeostasis. | ||||||